Hong Kong’s ICAC charges ex-biotech lab head over hiding conflict of interest
Former lab director of Hong Kong Molecular Pathology Diagnostic Centre awarded contract at testing centre to firm he controlled with others
Hong Kong’s anti-corruption agency has charged a former senior biotech executive over allegedly concealing a conflict of interest when selecting a subcontractor for a Covid-19 community testing centre, resulting in service payments totalling HK$120 million (US$15.4 million).
Chris Wong Lei-po, 56, former laboratory director of the Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC), was charged with one count of fraud on Wednesday by the Independent Commission Against Corruption (ICAC), which acted upon a corruption complaint.
HKMPDC, one of the operators of community testing centres, contracted out the registration and crowd control work to Health Conscience Limited, with the selection overseen by Wong.
Although Wong had set up and controlled Health Conscience with others, he did not declare his actual or potential conflict of interest.
It was alleged that Wong concealed or failed to disclose his interest in the subcontractor in 2022 to HKMPDC with the intent to defraud, and induced it to award the service agreement for the daily operations of the community testing centre to Health Conscience.
The service payment made to the subcontractor totalled HK$120 million.